American Journal of Clinical Oncology · 1990 · 16 citations · 0 references
MedicineOncologyPharmacologyCancer Drug Toxicity ManagementChemotherapyPulmonologyAdverse Effects Of ChemotherapyChemotherapy Toxicity ManagementPalliative ChemotherapyPulmonary ToxicityPulmonary Toxicity ManagementCancer Therapy-related Pulmonary ToxicityChemotherapy-induced Pulmonary ToxicityDrug-induced Lung DiseaseDrug-induced Lung InjuryDrug-induced PneumonitisDrug-related PneumonitisProcarbazine TherapyPulmonary Toxicity Mechanisms
A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine. The pulmonary toxicity began 1 week after procarbazine had been discontinued and once recognized was successfully treated with intravenous steroids.